- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4029EUR$4,490USD£3,467GBP
- Report
- May 2023
- 105 Pages
Global
From €3500EUR$4,178USD£3,118GBP
The Septal Occluder market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat certain types of congenital heart defects, such as atrial septal defects (ASD). These devices are designed to close the hole in the wall between the two upper chambers of the heart, allowing the patient to lead a normal life. The Septal Occluder market is composed of a variety of products, including occluder devices, delivery systems, and accessories.
The Septal Occluder market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, and W.L. Gore & Associates. Other companies in the market include St. Jude Medical, Inc., CryoLife, Inc., and Occlutech International AB. Show Less Read more